Thomas Joseph Povsic, MD

Associate Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Duke Box 103208, Durham, NC 27710
Email address povsi001@mc.duke.edu

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1998 - 2004
  • Medical Resident, Medicine, Duke University, 1995 - 1998
  • M.D., Harvard University , 1995

Publications

Povsic, Thomas J., E Magnus Ohman, Matthew T. Roe, Jennifer White, Frank W. Rockhold, Gilles Montalescot, Jan H. Cornel, et al. “P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes..” In Jama Cardiol, 4:680–84, 2019. https://doi.org/10.1001/jamacardio.2019.1510.

PMID
31141104
Full Text

Normand, Camilla, David M. Kaye, Thomas J. Povsic, and Kenneth Dickstein. “Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology..” Lancet 393, no. 10175 (March 9, 2019): 1045–55. https://doi.org/10.1016/S0140-6736(18)32216-5.

PMID
30860030
Full Text

Fanaroff, Alexander C., Robert Clare, Karen S. Pieper, Kenneth W. Mahaffey, Chiara Melloni, Jennifer B. Green, John H. Alexander, et al. “Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials..” Circulation 139, no. 7 (February 12, 2019): 863–73. https://doi.org/10.1161/CIRCULATIONAHA.118.037202.

PMID
30586739
Full Text

Hernandez, Adrian F., Jennifer B. Green, Salim Janmohamed, Ralph B. D’Agostino, Christopher B. Granger, Nigel P. Jones, Lawrence A. Leiter, et al. “Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial..” Lancet 392, no. 10157 (October 27, 2018): 1519–29. https://doi.org/10.1016/S0140-6736(18)32261-X.

PMID
30291013
Full Text

Fanaroff, Alexander C., Valarie Morrow, Mitchell W. Krucoff, Jonathan H. Seltzer, Emerson C. Perin, Doris A. Taylor, Leslie W. Miller, et al. “A Path Forward for Regenerative Medicine..” Circ Res 123, no. 4 (August 3, 2018): 495–505. https://doi.org/10.1161/CIRCRESAHA.118.313261.

PMID
30355250
Full Text

Henry, Timothy D., Douglas W. Losordo, Jay H. Traverse, Richard A. Schatz, E Marc Jolicoeur, Gary L. Schaer, Robert Clare, et al. “Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials..” Eur Heart J 39, no. 23 (June 14, 2018): 2208–16. https://doi.org/10.1093/eurheartj/ehx764.

PMID
29315376
Full Text

Brilakis, Emmanouil S., Robert Edson, Deepak L. Bhatt, Steven Goldman, David R. Holmes, Sunil V. Rao, Kendrick Shunk, et al. “Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial..” Lancet 391, no. 10134 (May 19, 2018): 1997–2007. https://doi.org/10.1016/S0140-6736(18)30801-8.

PMID
29759512
Full Text

Pages